Treatment of schizophrenia negative symptoms: future prospects.
New findings from neuroscience, genetics, and experimental psychology have emerged that provide alternative explanations of many negative symptoms. We review the continuing limitations in treatment and discuss possible sources of heterogeneity among negative symptoms. We also anticipate conceptual uncertainties that may arise with forthcoming treatment developments.
Erhart
Stephen M
SM
UCLA Department of Psychiatry and Biobehavioral Sciences, USA. serhart@ucla.edu
Marder
Stephen R
SR
Carpenter
William T
WT
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004358:Drug Therapy / Q000639:trends*; D005544:Forecasting; D005625:Frontal Lobe / Q000503:physiopathology; D006801:Humans; D050638:Receptors, Dopamine D4 / Q000187:drug effects / Q000235:genetics; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D012565:Schizophrenic Psychology; D011795:Surveys and Questionnaires
D014150:Antipsychotic Agents; D050638:Receptors, Dopamine D4